Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · IEX Real-Time Price · USD
2.780
+0.120 (4.51%)
At close: Jul 19, 2024, 12:00 AM
2.800
+0.020 (0.72%)
Pre-market: Jul 22, 2024, 8:41 AM EDT
Trevi Therapeutics Employees
Trevi Therapeutics had 25 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
25
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,342,640
Market Cap
195.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
P3 Health Partners | 400 |
EDAP TMS | 307 |
Personalis | 225 |
CVRx, Inc. | 200 |
Generation Bio Co. | 174 |
ClearPoint Neuro | 107 |
G1 Therapeutics | 100 |
Renovaro Biosciences | 12 |
TRVI News
- 20 days ago - Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events - PRNewsWire
- 2 months ago - Trevi Therapeutics to Participate in Upcoming Conferences - PRNewsWire
- 2 months ago - Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates - PRNewsWire
- 2 months ago - Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024 - PRNewsWire
- 3 months ago - Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference - PRNewsWire
- 3 months ago - Trevi Therapeutics to Participate in Upcoming April Events - PRNewsWire
- 3 months ago - Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team - PRNewsWire
- 4 months ago - Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates - PRNewsWire